On Monday, Cantor Fitzgerald analyst Andres Sheppard reaffirmed an Overweight rating with a $10.00 price target on shares of Aurora Innovation Inc (NASDAQ: NASDAQ:AUR), expressing confidence in the ...

Fintel reports that on March 20, 2025, Cantor Fitzgerald initiated coverage of Titan International (NYSE:TWI) with a Overweight recommendation. Analyst Price Forecast Suggests 47.01% Upside As of ...

Nigeria ranked 105th globally and 10th in Africa in the latest Global Happiness Report, with Finland maintaining its position as the happiest country. Economic instability, insecurity, corruption, and ...

Lutnick divested his business interests in Cantor Fitzgerald upon becoming Trump’s secretary of commerce precisely to avoid any potential conflicts of interest. His sons Brandon and Kyle were ...

As the world marks the International Day of Happiness, Nigeria has been ranked 105th out of 147 countries in the latest Global Happiness Report. The country also sits in tenth position among ...

Tesla stock was upgraded to 'Overweight' by Cantor Fitzgerald amid its sharp decline. Analyst Andres Sheppard cites Tesla's future projects like its Robotaxi and autonomous vehicles as growth drivers.

Freeman K. Johnson, the oldest living survivor of the Pearl Harbor attack, celebrated his 105th birthday with a ceremony in Hyannis. Johnson was a machinist on the USS St. Louis during the attack ...

Fintel reports that on March 19, 2025, Cantor Fitzgerald upgraded their outlook for Tesla (NasdaqGS:TSLA) from Neutral to ...

Tesla (NASDAQ:TSLA) attracted an upgrade from Cantor Fitzgerald on Wednesday after the firm visited the company's Gigafactory and AI data centers in Austin. The firm moved Tesla (NASDAQ ...

Stock analysts at Cantor Fitzgerald, the firm long led by now-U.S. Commerce Secretary Howard Lutnick, upgraded their rating on Tesla Inc., the carmaker run by White House adviser Elon Musk. Tesla’s ...

Cantor Fitzgerald upgraded Tesla (TSLA, Financials) to Overweight from Neutral, citing a buying opportunity following the recent sell-off, the firm announced after a site visit to Tesla's ...

Cantor Fitzgerald assumed coverage of Aclaris Therapeutics (ACRS) with an Overweight rating. Cantor is bullish on the TSLP and IL-4R bispecific, which looks differentiated, and even early proof-of ...